← Back to Search

ENGAGE for Stroke

N/A
Waitlist Available
Led By Elizabeth R Skidmore, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1 vs week 7
Awards & highlights

Study Summary

This trial is testing a new community-based intervention to help people with stroke participate in their community. The trial will see if the intervention is feasible, acceptable, and safe, and will also help researchers plan a larger trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1 vs week 7
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1 vs week 7 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability, Indicated by Score 24 or Higher Out of 32 on the Client Satisfaction Questionnaire
Adverse Events, Defined as Reported Injuries or Injurious Falls
Fidelity, Indicated by Score of 18 or Higher Out of 20 on the ENGAGE Fidelity Checklist
Secondary outcome measures
Cohen's d Effect Size of the Change From Week 1 to Week 7 in PROMIS Ability to Participate in Social Roles

Trial Design

1Treatment groups
Experimental Treatment
Group I: ENGAGEExperimental Treatment1 Intervention
The intervention blends social learning, guided discovery, and skill training to promote community participation after stroke. The intervention is delivered in a group format and comprises group learning activities and individual action planning activities that address barriers to community participation after stroke.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ENGAGE
2013
Completed Phase 2
~180

Find a Location

Who is running the clinical trial?

National Center for Advancing Translational Sciences (NCATS)NIH
319 Previous Clinical Trials
401,631 Total Patients Enrolled
6 Trials studying Stroke
688 Patients Enrolled for Stroke
National Institutes of Health (NIH)NIH
2,690 Previous Clinical Trials
6,950,970 Total Patients Enrolled
38 Trials studying Stroke
7,762 Patients Enrolled for Stroke
University of PittsburghLead Sponsor
1,718 Previous Clinical Trials
16,342,286 Total Patients Enrolled
26 Trials studying Stroke
2,666 Patients Enrolled for Stroke

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is access to this trial available for those who meet the criteria?

"As reported on clinicaltrials.gov, the study is currently not accepting participants. The trial was first posted in September 2019 and last edited on August 2022. Luckily for those looking to join a medical experiment, there are 1043 trials presently recruiting subjects."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
ENGAGE Pilot Study: Promoting Participation and Health After Stroke
Elizabeth R. Skidmore, PhD, OTR/L 2019. "ENGAGE Pilot Study: Promoting Participation and Health After Stroke". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04019275.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top